| Product Code: ETC10765615 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of Pemetrexed to Israel in 2024 saw a diverse range of top exporting countries including Switzerland, UK, Belgium, USA, and Germany. Despite this variety, the market remained highly competitive with a low concentration level indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, reflecting a slight decline in demand over the period. Additionally, the growth rate from 2023 to 2024 was -0.41%, suggesting a further slowdown in the market for Pemetrexed imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pemetrexed Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pemetrexed Market - Industry Life Cycle |
3.4 Israel Pemetrexed Market - Porter's Five Forces |
3.5 Israel Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Israel Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Israel Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Israel Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Pemetrexed Market Trends |
6 Israel Pemetrexed Market, By Types |
6.1 Israel Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Israel Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Israel Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Israel Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Israel Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Israel Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Israel Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Israel Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Israel Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Israel Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Israel Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Israel Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Israel Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Israel Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Israel Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Israel Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Israel Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Israel Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Israel Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Israel Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Israel Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Israel Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Israel Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Israel Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Israel Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Israel Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Israel Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Israel Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Israel Pemetrexed Market Import-Export Trade Statistics |
7.1 Israel Pemetrexed Market Export to Major Countries |
7.2 Israel Pemetrexed Market Imports from Major Countries |
8 Israel Pemetrexed Market Key Performance Indicators |
9 Israel Pemetrexed Market - Opportunity Assessment |
9.1 Israel Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Israel Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Israel Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Israel Pemetrexed Market - Competitive Landscape |
10.1 Israel Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Israel Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here